Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02829775
What this trial is testing

Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies

Who this might be right for
Chronic Myelogenous LeukemiaMalignant MelanomaRenal Cell Carcinoma
Hoffmann-La Roche 9
Testing effectiveness (Phase 2)Study completedNCT00199901
What this trial is testing

Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma

Who this might be right for
Melanoma
Ludwig Institute for Cancer Research 111
Early research (Phase 1)Active Not RecruitingNCT05538130
What this trial is testing

Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Who this might be right for
MelanomaGliomaThyroid Cancer+10 more
Pfizer 148
Not applicableStudy completedNCT07334600
What this trial is testing

Effect of 1% Andaliman Fruit Extract Cream on Facial Seborrheic Keratosis

Who this might be right for
Seborrheic Keratosis
Universitas Sumatera Utara 40
Testing effectiveness (Phase 2)UnknownNCT04225767
What this trial is testing

Calcium Electroporation as a Treatment for Cutaneous and Subcutaneous Malignant Tumours

Who this might be right for
Cancer
Zealand University Hospital 19
Large-scale testing (Phase 3)UnknownNCT00002767
What this trial is testing

Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
GlaxoSmithKline 300
Early research (Phase 1)Active Not RecruitingNCT02204098
What this trial is testing

Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy

Who this might be right for
Breast CancerBreast CarcinomaMalignant Neoplasm of Breast
Washington University School of Medicine 27
Not applicableStudy completedNCT04524728
What this trial is testing

Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy

Who this might be right for
BreastNeoplasm MalignantFemale
Istituti Clinici Scientifici Maugeri SpA 191
Testing effectiveness (Phase 2)Study completedNCT00616564
What this trial is testing

Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma

Who this might be right for
Malignant Melanoma
Mt. Sinai Medical Center, Miami 36
Testing effectiveness (Phase 2)Study completedNCT00244816
What this trial is testing

Taxoprexin® Treatment for Advanced Eye Melanoma

Who this might be right for
Metastatic Melanoma
American Regent, Inc. 22
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableStudy completedNCT07319767
What this trial is testing

Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors

Who this might be right for
Breast CancerPancreatic Adenocarcinoma (Ductal Adenocarcinoma)Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)
Shanghai Zhongshan Hospital 120
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Early research (Phase 1)Study completedNCT03012230
What this trial is testing

Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast Cancer

Who this might be right for
Metastatic Malignant Neoplasm in the BoneStage IV Breast Cancer AJCC v6 and v7Triple-Negative Breast Carcinoma
Mayo Clinic 12
Early research (Phase 1)Study completedNCT01844674
What this trial is testing

A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies

Who this might be right for
Malignant Melanoma, Neoplasms
Hoffmann-La Roche 18
Not applicableUnknownNCT01002560
What this trial is testing

The Identification of Novel Prognostic Markers in Melanoma

Who this might be right for
Malignant Melanoma
Royal Marsden NHS Foundation Trust 500
Testing effectiveness (Phase 2)Study completedNCT00281541
What this trial is testing

The Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma

Who this might be right for
Melanoma
Astellas Pharma Inc 29
Testing effectiveness (Phase 2)Looking for participantsNCT06560905
What this trial is testing

Preoperative Planning With PSMA-PET in Melanoma Surgery Trial

Who this might be right for
Malignant Melanoma
Royal Marsden NHS Foundation Trust 16
Testing effectiveness (Phase 2)Looking for participantsNCT06965231
What this trial is testing

Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial

Who this might be right for
Melanoma of SkinAcral MelanomaStage II Melanoma
Fudan University 58
Not applicableWithdrawnNCT03261323
What this trial is testing

Breast Reconstruction Following Breast Cancer in Very High Risk Patients

Who this might be right for
Breast CancerMalignant Neoplasm of Breast
Case Comprehensive Cancer Center
Next Page